Navigation Links
Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
Date:8/21/2008

NEW DELHI, August 21 /PRNewswire/ -- Omaxe Infrastructure & Construction Private Ltd(OICPL), a wholly owned subsidiary of Omaxe Ltd has received a Letter of Intent for the construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP from UP Government through UP RNNL. The construction value of the project is Rs250 crores approx.

The project is spread over an area of 62 acres with total built up area of 15.66 lac sq ft. It will comprise of an Allopathic Medical College and a 500-bedded hospital.

OICPL will also construct an Academic building, an auditorium, academic hospital building. Apart from this, there will be hostels for students, a separate hostel for nurses and resident doctors, guest house, autopsy building, pump house, and principal residence.

According to Mr. Rohtas Goel, CMD, Omaxe Ltd., "Omaxe Infrastructure & Construction Private Ltd is an outcome of Omaxe Ltd's strategic plan to diversify its business into new markets. The announcement is consistent with our company vision of providing state-of-art infrastructure and creating opportunities to help meet local and global infrastructure demands. Omaxe Infrastructure & Construction Private Ltd is slated to bid for other larger infrastructure projects".

The construction of the project will be completed in two years.

The financial standing of Omaxe Ltd and rising demand of the projects will further add to its value. Omaxe Ltd has prepaid 60% (Rs 180 crore) of the total term facility (Rs 300 crore) taken by the company from Indiabulls Financial Services Limited. Inspite of this term facility being for a period of 3 years , all dues being serviced in time and a substantially higher collateral security lying with the lender, it has been felt by the company to prepay the loan in order to free up the equity. Omaxe is planning to retire the outstanding of Rs 120 crore in near future. This step of Omaxe Ltd shall further strengthen the trust of investors in the company.

For more details, please contact:

Dhananjay Srivastava

DGM - PR & Media

Omaxe House

Mobile:+91(0)9818099270

Anurag Nigam / Neeti Mathur

Adfactors PR Pvt Ltd

Mobile: +91(0)9818296645 / +91(0)9871551232


'/>"/>
SOURCE Omaxe Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Osteotechs Plexur(R) Technology to Be Used in Craniofacial Reconstruction Program Funded by the Armed Forces Institute of Regenerative Medicine
2. Cellular construction methods emulated
3. Enerkem announces progress on construction of Canadas first cellulosic ethanol plant
4. DNA is blueprint, contractor and construction worker for new structures
5. White Paper Details Infection Control Challenges Hospitals Must Address During Construction
6. China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility
7. TEI Biosciences Launches SurgiMend(TM) Collagen Matrix for Soft Tissue Reconstruction
8. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
9. MicroTech Ranks No. 285 on Inc. Magazines 2008 List of the 500 Fastest Growing Private Companies in America
10. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
11. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... World Technology Awards. uBiome is one of just six company finalists in the ... In addition to uBiome, companies nominated as finalists in this year’s awards include ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016 Soligenix, ... biopharmaceutical company focused on developing and commercializing products to ... need, announced today that it will be hosting an ... am ET on the origins of innate defense regulators ... a review of oral mucositis and the recently announced ...
(Date:12/8/2016)... Eutilex Co. Ltd. today announced that it ... A financing. This financing round included participation from DS ... Bio Angel. This new funding brings the total capital ... since its founding in 2015. The ... commercialization of its immuno-oncology programs, expand its R&D capabilities ...
(Date:12/7/2016)... San Diego (PRWEB) , ... December 07, 2016 ... ... safety data from its phase I/II dose escalation and expansion clinical trial for ... 2016 in Vienna, Austria. The purpose of the trial was to determine the ...
Breaking Biology Technology:
(Date:11/22/2016)... Nov. 22, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Healthcare and Life Sciences Awards as "Most Outstanding ... an unprecedented year of recognition and growth for MedNet, ... 15 years. iMedNet ™ , ...
(Date:11/16/2016)... Nov. 16, 2016 Sensory Inc ., ... security for consumer electronics, and VeriTran , ... retail industry, today announced a global partnership that ... to authenticate users of mobile banking and mobile ... software which requires no specialized biometric scanners, ...
(Date:6/27/2016)... Research and Markets has announced the addition ... to their offering. The report ... to grow at a CAGR of 12.28% during the period 2016-2020. ... in-depth market analysis with inputs from industry experts. The report covers ... The report also includes a discussion of the key vendors operating ...
Breaking Biology News(10 mins):